Cargando…
High FOXM1 expression is a prognostic marker for poor clinical outcomes in prostate cancer
Purpose: We aimed to investigate the expression of FOXM1 and to determine the relationships between FOXM1 expression and clinicopathologic characteristics in patients with PCa. Furthermore, we reconfirmed the prognostic impact of FOXM1 in different cohorts using already published data. Patients and...
Autores principales: | Kim, Mee Young, Jung, Ae Ryang, Kim, Ga Eun, Yang, Jonghyup, Ha, U-Syn, Hong, Sung-Hoo, Choi, Yeong Jin, Moon, Mi Hyoung, Kim, Sae Woong, Lee, Ji Youl, Park, Yong Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360432/ https://www.ncbi.nlm.nih.gov/pubmed/30719174 http://dx.doi.org/10.7150/jca.28099 |
Ejemplares similares
-
GV1001 inhibits cell viability and induces apoptosis in castration-resistant prostate cancer cells through the AKT/NF-κB/VEGF pathway
por: Park, Yong Hyun, et al.
Publicado: (2019) -
Urovysion FISH Could Be Effective and Useful Method to Confirm the Identity of Cultured Circulating Tumor Cells from Bladder Cancer Patients
por: Kim, Tae-Jung, et al.
Publicado: (2019) -
Anthocyanin Induces Apoptosis of DU-145 Cells In Vitro and Inhibits Xenograft Growth of Prostate Cancer
por: Ha, U-Syn, et al.
Publicado: (2015) -
The Impact of Diabetes on the Risk of Prostate Cancer Development according to Body Mass Index: A 10-year Nationwide Cohort Study
por: Choi, Jin Bong, et al.
Publicado: (2016) -
Clinical Efficacy of Multi-Focal Low-Intensity Extracorporeal Shockwave Therapy in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Prospective-Randomized, Double Blind, Placebo-Controlled Study
por: Kim, Kang Sup, et al.
Publicado: (2022)